Head to head comparisons between [18F]-fluciclovine and PMSA PET-CT for identification of prostate cancer have been reported, although most involve comparison of [18F]-fluciclovine and [68Ga]-PSMA [92]. This evidence concerns the gene FOLH1 and prostate carcinoma.